OBIO
Price
$2.78
Change
-$0.31 (-10.03%)
Updated
Jun 27 closing price
Capitalization
106.51M
XERS
Price
$4.70
Change
-$0.04 (-0.84%)
Updated
Jun 27 closing price
Capitalization
752.73M
39 days until earnings call
Interact to see
Advertisement

OBIO vs XERS

Header iconOBIO vs XERS Comparison
Open Charts OBIO vs XERSBanner chart's image
Orchestra BioMed Holdings
Price$2.78
Change-$0.31 (-10.03%)
Volume$3.19M
Capitalization106.51M
Xeris Biopharma Holdings
Price$4.70
Change-$0.04 (-0.84%)
Volume$4.69M
Capitalization752.73M
OBIO vs XERS Comparison Chart in %
Loading...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OBIO vs. XERS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBIO is a Hold and XERS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (OBIO: $2.78 vs. XERS: $4.70)
Brand notoriety: OBIO and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OBIO: 999% vs. XERS: 215%
Market capitalization -- OBIO: $106.51M vs. XERS: $752.73M
OBIO [@Biotechnology] is valued at $106.51M. XERS’s [@Biotechnology] market capitalization is $752.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OBIO’s FA Score shows that 0 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • OBIO’s FA Score: 0 green, 5 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, XERS is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OBIO’s TA Score shows that 4 TA indicator(s) are bullish while XERS’s TA Score has 5 bullish TA indicator(s).

  • OBIO’s TA Score: 4 bullish, 4 bearish.
  • XERS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XERS is a better buy in the short-term than OBIO.

Price Growth

OBIO (@Biotechnology) experienced а -7.64% price change this week, while XERS (@Biotechnology) price change was +4.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

XERS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XERS($753M) has a higher market cap than OBIO($107M). XERS YTD gains are higher at: 38.643 vs. OBIO (-30.500). XERS has higher annual earnings (EBITDA): -4.34M vs. OBIO (-68.48M). XERS has more cash in the bank: 58.4M vs. OBIO (49.9M). OBIO has less debt than XERS: OBIO (16.4M) vs XERS (269M). XERS has higher revenues than OBIO: XERS (223M) vs OBIO (2.89M).
OBIOXERSOBIO / XERS
Capitalization107M753M14%
EBITDA-68.48M-4.34M1,578%
Gain YTD-30.50038.643-79%
P/E RatioN/AN/A-
Revenue2.89M223M1%
Total Cash49.9M58.4M85%
Total Debt16.4M269M6%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OBIOXERS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGCX42.290.22
+0.52%
MFS Core Equity C
CVQZX8.890.03
+0.34%
Columbia Disciplined Value Inst
RPEAX40.280.06
+0.15%
Davis Opportunity A
TSMUX15.15N/A
N/A
Nuveen Quant Small/Mid Cap Eq W
WGGSX13.56N/A
N/A
Wasatch Global Select Institutional

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with XERS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-10.03%
XERS - OBIO
39%
Loosely correlated
-0.84%
ARWR - OBIO
39%
Loosely correlated
+0.06%
GLSI - OBIO
37%
Loosely correlated
+0.67%
OCUL - OBIO
37%
Loosely correlated
-2.54%
DNLI - OBIO
37%
Loosely correlated
-2.69%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
-0.84%
TRDA - XERS
51%
Loosely correlated
-1.57%
YMAB - XERS
45%
Loosely correlated
-2.08%
XNCR - XERS
45%
Loosely correlated
-3.10%
CGON - XERS
44%
Loosely correlated
-0.46%
KRYS - XERS
43%
Loosely correlated
-2.60%
More